Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19
Лёгочные и внелёгочные клинические проявления COVID-19
2020-08-13
SCID: 54.1/yt7e4zjf
Discuss with AI
COVID-19SARS-CoV-2acute respiratory distress syndromeextrapulmonary manifestationsmultiorgan involvement
Figures from the paper
Abstract (AI)
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been recently identified as the culprit of the highly infectious, outbreak named coronavirus disease 2019 (COVID-19) in China. Now declared a public health emergency, this pandemic is present in more than 200 countries with over 14 million cases and 600,000 deaths as of July 18, 2020. Primarily transmitted through the respiratory tract, the most common clinical presentations of symptomatic individuals infected with SARS-CoV-2 include fever, dyspnea, cough, fatigue, and sore throat. In advanced cases, patients may rapidly develop respiratory failure with acute respiratory distress syndrome, and even progress to death. While it is known that COVID-19 manifests similarly to the 2003 Severe Acute Respiratory Syndrome (SARS) and the 2012 Middle East Respiratory Syndrome (MERS), primarily affecting the pulmonary system, the impact of the disease extends far beyond the respiratory system and affects other organs of the body. The literature regarding the extrapulmonary manifestations (cardiovascular, renal, hepatic, gastrointestinal, ocular, dermatologic, and neurological) of COVID-19 is scant. Herein, we provide a comprehensive review of the organ-specific clinical manifestations of COVID-19, to increase awareness about the various organs affected by SARS-CoV-2 and to provide a brief insight into the similarities and differences in the clinical manifestations of COVID-19 and the earlier SARS and MERS.
Key Findings
1
Although SARS-CoV-2 infection predominantly affects the lungs, COVID-19 also involves cardiovascular, renal, hepatic, gastrointestinal, ocular, dermatologic, and neurological systems.
2
As of July 18, 2020, the pandemic had exceeded 14 million cases and 600,000 deaths across more than 200 countries.
3
COVID-19 primarily presents with fever, dyspnea, cough, fatigue, and sore throat, but severe disease can rapidly progress to respiratory failure, acute respiratory distress syndrome, and death.
4
The article provides an organ-specific review of COVID-19 manifestations and compares similarities and differences with SARS and MERS.
5
The review emphasizes that COVID-19 has broader extrapulmonary clinical manifestations than its primary respiratory presentation suggests.
Research Object
COVID-19 (SARS-CoV-2 infection) in human patients
Research Subject
Pulmonary and extrapulmonary, organ-specific clinical manifestations of COVID-19
Publication Details
Publication Date
2020-08-13
Journal
Publisher
ISSN
Cited by
175
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America2019
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients2020
A first case of meningitis/encephalitis associated with SARS-Coronavirus-22020
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza2020